Intensive Nutrition Incorporated
Letter data
- Company
- Intensive Nutrition Incorporated
- Recipient
- Olivia B. Melaugh | President | Intensive Nutrition Incorporated | Intensive Nutrition Incorporated | 1972 Republic Ave. | San Leandro | , | CA | 94577-4224 | United States
- Issue date
- 2018-10-09
- Posted date
- Not available
- FDA office
- OHAFO West Division 5
- Subject
- Not available
- Product
- Dietary Supplements
- CMS ID
- 395974
- Reference number
- Not available
- FEI
- Not available
- Inspection dates
- Not available
Normalized citations
21 CFR: None found
21 U.S.C.: None found
Related FDA links
No related FDA letter link is present in the source index.
Full source text
CLOSEOUT LETTER
Intensive Nutrition Incorporated
MARCS-CMS 395974 —
October 09, 2018
More Warning Letters
Warning Letters
About Warning and Close-Out Letters
Product:
Dietary Supplements
Recipient:
Recipient Name
Olivia B. Melaugh
Recipient Title
President
Intensive Nutrition Incorporated
Intensive Nutrition Incorporated
1972 Republic Ave.
San Leandro
,
CA
94577-4224
United States
Issuing Office:
OHAFO West Division 5
1431 Harbor Bay Parkway
Alameda
,
CA
94502
United States
October 9, 2018
RE: WL Close-Out Letter
Dear Ms. Melaugh:
The Food and Drug Administration has completed an evaluation of your firm's corrective actions in response to our Warning Letter, dated January 22, 2014. Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.
This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.
Sincerely,
/S/
Sergio Chavez
Director Compliance Branch
Food and Drug Administration
HAF Division West 5
Content current as of:
10/11/2018
Regulated Product(s)
Dietary Supplements